☆ 4.7 Letter

Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Get Full Text
Add to Collection

Journal

ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 47, Issue 10, Pages 1422-1423

Publisher

WILEY
DOI: 10.1111/apt.14603

Keywords

-

Categories

Gastroenterology & Hepatology Pharmacology & Pharmacy

Funding

  1. Takeda Pharmaceuticals

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.